Update on Gout and Hyperuricemia

J. F. Baker; H. Ralph Schumacher


Int J Clin Pract. 2010;64(3):371-377. 

In This Article


Gout is a common, burdensome and often challenging disease. Clinical diagnosis although easy in classical attacks can be challenging in some patients. Anti-inflammatory agents are critical for treatment of acute flares and for prophylaxis when initiating urate-lowering therapy. The importance of appropriate and aggressive urate-lowering phamacotherapy is often under-recognised. This should be undertaken in a goal-oriented approach to reach a SUA level of < 6.0 mg/dl. Patients with gout and hyperuricemia should be considered at increased risk for hypertension, cardiovascular disease and kidney disease.